carbamates has been researched along with Dyslipidemia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Healthy volunteer studies have demonstrated a decrease in glucose disposal associated with dosing with specific antiretrovirals." | 6.75 | Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men. ( Back, DJ; Boffito, M; Jackson, AG; Mandalia, S; Moyle, GJ; Randell, PA; Taylor, J; Tjia, JF, 2010) |
| " Healthy volunteer studies have demonstrated a decrease in glucose disposal associated with dosing with specific antiretrovirals." | 2.75 | Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men. ( Back, DJ; Boffito, M; Jackson, AG; Mandalia, S; Moyle, GJ; Randell, PA; Taylor, J; Tjia, JF, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CF | 1 |
| Dai, CY | 1 |
| Yeh, ML | 1 |
| Huang, CI | 1 |
| Lee, HC | 1 |
| Lai, WT | 1 |
| Liang, PC | 1 |
| Lin, YH | 1 |
| Hsieh, MY | 1 |
| Hou, NJ | 1 |
| Lin, ZY | 1 |
| Chen, SC | 1 |
| Huang, JF | 1 |
| Chuang, WL | 1 |
| Yu, ML | 1 |
| Jain, A | 1 |
| Kalra, BS | 1 |
| Srivastava, S | 1 |
| Chawla, S | 1 |
| Ucciferri, C | 1 |
| Falasca, K | 1 |
| Vignale, F | 1 |
| Di Nicola, M | 1 |
| Pizzigallo, E | 1 |
| Vecchiet, J | 1 |
| Helsley, RN | 1 |
| Sui, Y | 1 |
| Ai, N | 1 |
| Park, SH | 1 |
| Welsh, WJ | 1 |
| Zhou, C | 1 |
| Pombo, M | 1 |
| Olalla, J | 1 |
| Del Arco, A | 1 |
| De La Torre, J | 1 |
| Urdiales, D | 1 |
| Aguilar, A | 1 |
| Prada, JL | 1 |
| García-Alegría, J | 1 |
| Ruiz-Mateas, F | 1 |
| Randell, PA | 1 |
| Jackson, AG | 1 |
| Boffito, M | 1 |
| Back, DJ | 1 |
| Tjia, JF | 1 |
| Taylor, J | 1 |
| Mandalia, S | 1 |
| Moyle, GJ | 1 |
1 trial available for carbamates and Dyslipidemia
| Article | Year |
|---|---|
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men.
Topics: Adenine; Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Carbamates; Confidence Intervals; Dr | 2010 |
5 other studies available for carbamates and Dyslipidemia
| Article | Year |
|---|---|
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.
Topics: Aged; Antiviral Agents; Carbamates; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dys | 2020 |
Effect of sofosbuvir and daclatasvir on lipid profile, glycemic control and quality of life index in chronic hepatitis C, genotype 3 patients.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Carbamates; Cholesterol; Dexamethasone; D | 2019 |
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy.
Topics: Adult; Anti-HIV Agents; Blood Chemical Analysis; Carbamates; CD4 Lymphocyte Count; Darunavir; Dyslip | 2013 |
Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice.
Topics: Animals; Binding Sites; Carbamates; Cell Line; Dyslipidemias; Furans; Gene Expression; HIV Protease | 2013 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carba | 2013 |